Ligand validation:7Y0G

P15: 2,5,8,11,14,17-HEXAOXANONADECAN-19-OL

P15 is a Ligand Of Interest in 7Y0G designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7Y0G_P15_K_301	54%	61%	0.136	0.899	0.53	0.96	-	-	0	0	100%	1
7Y0G_P15_E_301	52%	63%	0.131	0.889	0.57	0.85	-	-	1	0	100%	1
7Y0G_P15_H_301	41%	62%	0.155	0.869	0.5	0.93	-	-	4	0	100%	1
7Y0G_P15_B_301	38%	55%	0.158	0.86	0.47	1.24	-	1	0	0	100%	1
7YIZ_P15_B_301	51%	60%	0.167	0.923	0.55	0.97	-	-	2	0	100%	1
7X3N_P15_D_301	26%	63%	0.235	0.876	0.72	0.71	-	1	2	0	100%	1
6BJ5_P15_C_401	66%	65%	0.133	0.937	0.72	0.64	1	-	2	0	100%	1
4A5X_P15_B_1082	55%	42%	0.156	0.923	0.75	1.46	-	1	1	0	100%	1
5FOQ_P15_B_1547	39%	63%	0.165	0.869	0.53	0.89	-	1	2	0	100%	1
2Y2V_P15_A_1546	38%	40%	0.214	0.916	0.56	1.73	-	4	7	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.